TY  - JOUR
AU  - Maleki-Vareki, Saman
AU  - Garrigos, Carmen
AU  - Duran, Ignacio
PY  - 2017
DO  - 10.1016/j.critrevonc.2017.06.001
UR  - http://hdl.handle.net/10668/11390
T2  - Critical reviews in oncology/hematology
AB  - Immunotherapy is a promising treatment strategy for cancer that has recently shown unprecedented survival benefits in selected patients. A number of immunomodulatory agents that target immune system checkpoints such as the cytotoxic T-lymphocyte...
LA  - en
PB  - Elsevier Ireland Ltd.
KW  - Biomarkers
KW  - Cancer
KW  - Immunotherapy
KW  - PD-1
KW  - PD-L1
KW  - Antineoplastic Agents
KW  - B7-H1 Antigen
KW  - Biomarkers
KW  - Humans
KW  - Immunotherapy
KW  - Neoplasms
KW  - Prognosis
KW  - Programmed Cell Death 1 Receptor
TI  - Biomarkers of response to PD-1/PD-L1 inhibition.
TY  - research article
VL  - 116
ER  -